Improved Reperfusion and Neuroprotection by Creatine in a Mouse Model of Stroke
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Stroke leads to energy failure and subsequent neuronal cell loss. Creatine and phosphocreatine constitute a cellular energy buffering and transport system, and dietary creatine supplementation was shown to protect neurons in several models of neurodegeneration. Although creatine has recently been found to reduce infarct size after cerebral ischemia in mice, the mechanisms of neuroprotection remained unclear. We provide evidence for augmented cerebral blood flow (CBF) after stroke in creatine-treated mice using a magnetic resonance imaging (MRI)-based technique of CBF measurement (flow-sensitive alternating inversion recovery-MRI). Moreover, improved vasodilatory responses were detected in isolated middle cerebral arteries obtained from creatine-treated animals. After 3 weeks of dietary creatine supplementation, minor changes in brain creatine, phosphocreatine, adenosine triphosphate, adenosine diphosphate and adenosine monophosphate levels were detected, which did not reach statistical significance. However, we found a 40% reduction in infarct volume after transient focal cerebral ischemia. Our data suggest that creatine-mediated neuroprotection can occur independent of changes in the bioenergetic status of brain tissue, but may involve improved cerebrovascular function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is evidence from animal models that creatine supplementation is neuroprotective [147–149] and can reduce the severity of spinal cord injury [150, 151], cerebral ischemia [152–155], and concussion/traumatic brain injury [2, 7, 12, 22, 32, 33, 156].”
From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [152]
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943
Self-citationDetre, J. A., Leigh, J. S., Williams, D. S., & Koretsky, A. P. (1992) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910230106 · Cited by 1,571
Use of MTT colorimetric assay to measure cell activation
Gerlier, D., & Thomasset, N. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90215-2 · Cited by 1,197
Kim, S. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910340303 · Cited by 1,001
What is the Correct Value for the Brain-Blood Partition Coefficient for Water?
Herscovitch, P., & Raichle, M. E. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.9 · Cited by 705
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Nature Medicine · doi:10.1038/6568 · Cited by 682
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Ruscher, K., Freyer, D., Karsch, M., Isaev, N., Megow, D., Sawitzki, B., Priller, J., Dirnagl, U., & Meisel, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10291.2002 · Cited by 462
Self-citationNeuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease
Matthews, R. T., Yang, L., Jenkins, B. G., Ferrante, R. J., Rosen, B. R., Kaddurah-Daouk, R., & Beal, M. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00156.1998 · Cited by 430
Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity
Matthews, R. T., Ferrante, R. J., Klivenyi, P., Yang, L., Klein, A. M., Mueller, G., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7049 · Cited by 373
Dietary supplement creatine protects against traumatic brain injury
Sullivan, P. G., Geiger, J. D., Mattson, M. P., & Scheff, S. W. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<723::aid-ana5>3.0.co;2-w · Cited by 309
Hypoxia-Induced Stroke Tolerance in the Mouse Is Mediated by Erythropoietin
Prass, K., Scharff, A., Ruscher, K., Löwl, D., Muselmann, C., Victorov, I., Kapinya, K., Dirnagl, U., & Meisel, A. (2003) · Stroke · doi:10.1161/01.str.0000080381.76409.b2 · Cited by 286
Self-citationBrewer, G. J., & Wallimann, T. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741968.x · Cited by 230 · cited 1×
“In addition, creatine reduced beta-amyloid toxicity, as well as glutamate excitoxicity, in cultured hippocampal neurons (Brewer and Wallimann, 2000).”
BackgroundSelf-citationWallimann, T., Dolder, M., Schlattner, U., Eder, M., Hornemann, T., O'Gorman, E., Rück, A., & Brdiczka, D. (1998) · BioFactors · doi:10.1002/biof.5520080310 · Cited by 230 · cited 1×
“Creatine kinase can generate adenosine triphosphate (ATP) from phosphocreatine and adenosine diphosphate (ADP) at the sites of high-energy demand and restore phosphocreatine for energy storage (Wallimann et al, 1998).”
BackgroundSelf-citationSestili, P., Martinelli, C., Bravi, G., Piccoli, G., Curci, R., Battistelli, M., Falcieri, E., Agostini, D., Gioacchini, A. M., & Stocchi, V. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.035 · Cited by 220
Inhibition of the Mitochondrial Permeability Transition by Creatine Kinase Substrates
Dolder, M., Walzel, B., Speer, O., Schlattner, U., & Wallimann, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208705200 · Cited by 194
Self-citationCreatine monohydrate increases strength in patients with neuromuscular disease
Tarnopolsky, M., & Martin, J. (1999) · Neurology · doi:10.1212/wnl.52.4.854 · Cited by 165
Hata, R., Maeda, K., Hermann, D., Mies, G., & Hossmann, K.-A. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200002000-00012 · Cited by 145
Prophylactic Creatine Administration Mediates Neuroprotection in Cerebral Ischemia in Mice
Zhu, S., Li, M., Figueroa, B. E., Liu, A., Stavrovskaya, I. G., Pasinelli, P., Beal, M. F., Brown, R. H., Kristal, B. S., Ferrante, R. J., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1278-04.2004 · Cited by 138 · cited 5×
“These findings are in line with recently published results using a more severe MCAO model in mice (Zhu et al, 2004).”
BackgroundResultInfluentialIpsiroglu, O. S., Stromberger, C., Ilas, J., Höger, H., Mühl, A., & Stöckler-Ipsiroglu, S. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01268-1 · Cited by 122
Tsekos, N. V., Zhang, F., Merkle, H., Nagayama, M., ladecola, C., & Kim, S. (1998) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910390409 · Cited by 105
Selivanov, V. A., Alekseev, A. E., Hodgson, D. M., Dzeja, P. P., & Terzic, A. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000009872.35940.7d · Cited by 100
Adcock, K. H., Nedelcu, J., Loenneker, T., Martin, E., Wallimann, T., & Wagner, B. P. (2002) · Developmental Neuroscience · doi:10.1159/000069043 · Cited by 97 · cited 1×
“Creatine protected neurons from anoxia in vitro (Carter et al, 1995; Parodi et al, 2003) and from hypoxia–ischemia in neonatal rat brain (Adcock et al, 2002).”
BackgroundSelf-citationLindauer, U., Vogt, J., Schuh‐Hofer, S., Dreier, J. P., & Dirnagl, U. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000088764.02615.b7 · Cited by 97
Self-citationAndres, R. H., Huber, A. W., Schlattner, U., Pérez-Bouza, A., Krebs, S. H., Seiler, R. W., Wallimann, T., & Widmer, H. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.004 · Cited by 86
Self-citationCarter, A. J., Müller, R. E., Pschorn, U., & Stransky, W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64062691.x · Cited by 83
Kinetics of creatine in blood and brain after intraperitoneal injection in the rat
Perasso, L., Cupello, A., Lunardi, G. L., Principato, M. C., Gandolfo, C., & Balestrino, M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02547-2 · Cited by 76
Fürst, W., & Hallström, S. (1992) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(92)80222-c · Cited by 63
Andres, R. H., Ducray, A. D., Huber, A. W., Pérez‐Bouza, A., Krebs, S. H., Schlattner, U., Seiler, R. W., Wallimann, T., & Widmer, H. R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03337.x · Cited by 58
Self-citationGuerrero, M. L., Beron, J., Spindler, B., Groscurth, P., Wallimann, T., & Verrey, F. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.2.c697 · Cited by 55
Self-citationBlasig, I. E., Giese, H., Schroeter, M. L., Sporbert, A., Utepbergenov, D., Buchwalow, I., Neubert, K., Schönfelder, G., Freyer, D., Schimke, I., et al. (2001) · Microvascular Research · doi:10.1006/mvre.2001.2318 · Cited by 50
Self-citationKennan, R. P., Suzuka, S. M., Nagel, R. L., & Fabry, M. E. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20014 · Cited by 41
Ishida, Y., Wyss, M., Hemmer, W., & Wallimann, T. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80548-h · Cited by 33
Self-citationFunctional aspects of creatine kinase isoenzymes in endothelial cells
Decking, U. K. M., Alves, C., Wallimann, T., Wyss, M., & Schrader, J. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.1.c320 · Cited by 28
Self-citationThe effects of potassium on the rat middle cerebral artery
Golding, E. M., Steenberg, M. L., Johnson, T. D., & Bryan, R. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02793-1 · Cited by 23
Pell, G. S., Lythgoe, M. F., Thomas, D. L., Calamante, F., King, M. D., Gadian, D. G., & Ordidge, R. J. (1999) · Stroke · doi:10.1161/01.str.30.6.1263 · Cited by 15
Role of K+ in regulating hypoxic cerebral blood flow in the rat: effect of glibenclamide and ouabain
Reid, J. M., & Paterson, D. J. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.1.h45 · Cited by 14
Parodi, M., Rebaudo, R., Perasso, L., Gandolfo, C., Cupello, A., & Balestrino, M. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03976-8 · Cited by 10
Research works printed but not linked: 1
- Reid JM, 1996, Am J Physiol, 270, H45
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“Similarly, Prass and colleagues [139] reported findings that creatine administration reduced brain infarct size following an ischemic event by 40%.”
BackgroundThe creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
Self-citationWu, G. (2020) · Amino Acids · doi:10.1007/s00726-020-02823-6 · Cited by 475
Functions and effects of creatine in the central nervous system
Andres, R. H., Ducray, A. D., Schlattner, U., Wallimann, T., & Widmer, H. R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.02.035 · Cited by 368
Self-citationCreatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement
Brosnan, J. T., & Brosnan, M. E. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093621 · Cited by 347
Metadata
- Authors
- Prass, K., Royl, G., Lindauer, U., Freyer, D., Megow, D., Dirnagl, U., Stöckler-Ipsiroglu, G., Wallimann, T., & Priller, J.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- University of Vienna (AT)
- ETH Zurich (CH)
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2007-03
- Volume
- 27
- Issue
- 3
- Pages
- 452-459
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2026671178
- Cited by
- 128
- References
- 39
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 8 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 3 · 2016: 8 · 2015: 7 · 2014: 7 · 2013: 8 · 2012: 5
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- creatine, neuroprotection, stroke, cerebral ischemia, reperfusion, cerebral blood flow, vasodilation, middle cerebral artery, infarct size, brain energy metabolism, phosphocreatine, adenosine nucleotides, dietary supplementation, focal cerebral ischemia
- MeSH terms
- Adenosine Triphosphate, Animals, Brain, Brain Ischemia, Cerebrovascular Circulation, Creatine, Disease Models, Animal, Magnetic Resonance Imaging, Male, Phosphocreatine, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.